Inventor
Corey REEVES
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes30%
C07BGeneral methods of organic chemistry4%
PatentTitleYear
12,522,596Compounds as GLP-1R agonists202612,486,261Compounds as GLP-1R agonists202512,473,289Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use202512,410,163Compounds as GLP-IR agonists202512,378,239Compounds as GLP-1R agonists202512,378,237Compounds as GLP-1R agonists202512,378,238Compounds as GLP-1R agonists202512,378,236Compounds as GLP-1R agonists202512,024,507Compounds as GLP-1R agonists2024Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2024–2026Patents assigned to TERNS PHARMACEUTICALS INC (8)· patent assignee history
2024–2026Based in US· patent location history
2025Patents assigned to AMGEN INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TERNS PHARMACEUTICALS INC | 8 | 2024–2026 |
| AMGEN INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2024–2026 |